Combination chemotherapy with 13-cis-retinoic acid and celecoxib in the treatment of glioblastoma multiforme
- 29 November 2005
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 78 (1) , 85-90
- https://doi.org/10.1007/s11060-005-9062-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- 13-cis-Retinoic acid in the treatment of recurrent glioblastoma multiformeNeuro-Oncology, 2004
- Differential Effects of Selective COX-2 Inhibitors on Cell Cycle Regulation and Proliferation of Glioblastoma Cell LinesCancer Biology & Therapy, 2004
- Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.2001
- Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cellsMolecular Brain Research, 2001
- Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398.2000
- Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivoActa Neuropathologica, 1999
- Fenretinide activates caspases and induces apoptosis in gliomas.1999
- Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells.1997
- The treatment of recurrent cerebral gliomas with all-trans-retinoic acid (tretinoin).Journal of Neuro-Oncology, 1997
- Inhibition of epidermal growth factor receptor activity by retinoic acid in glioma cellsJournal of Cellular Biochemistry, 1990